FDA Inspection 1336222 — Ningbo Renjian Pharmaceutical Group Co., Ltd
The FDA completed an inspection of Ningbo Renjian Pharmaceutical Group Co., Ltd on Aug 7, 2026 in Ningbo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 7, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ningbo (China)